TherapeuticsMD (TXMD) Cash from Investing Activities Growth (5y) (2016 - 2022)
TherapeuticsMD (TXMD) Cash from Investing Activities Growth (5y) (2016 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 26.77% |
| Sep 30, 2022 | 15.96% |
| Jun 30, 2022 | 22.29% |
| Mar 31, 2022 | -9.39% |
| Dec 31, 2021 | -31.03% |
| Sep 30, 2021 | 1.90% |
| Jun 30, 2021 | 29.14% |
| Mar 31, 2021 | -21.56% |
| Dec 31, 2020 | -1.85% |
| Sep 30, 2020 | -46.22% |
| Jun 30, 2020 | -47.32% |
| Mar 31, 2020 | -64.43% |
| Dec 31, 2019 | -122.20% |
| Sep 30, 2019 | -170.87% |
| Jun 30, 2019 | -60.85% |
| Mar 31, 2019 | -40.65% |
| Dec 31, 2018 | -17.30% |
| Sep 30, 2018 | -294.47% |
| Jun 30, 2018 | -14.79% |
| Mar 31, 2018 | -11.69% |